Why the study?
Findings regarding the association and interplay between familial hypercholesterolemia and diabetes are conflicting, with knowledge gaps remaining regarding their combined impact on lipid profile and cardiovascular risk.
Design
Review
Authors
Loading...
FH may protect against diabetes; leaves open whether statins attenuate this benefit in practice.
This review highlights the complex and conflicting evidence regarding the interplay between familial hypercholesterolemia, lipid-lowering treatments, and the risk of developing diabetes.
González-Lleó et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: